{"id":"tp-59744","type":"article-newspaper","title":"FDA Grants Accelerated Approval to GSK’s Neladalkib for Lung Cancer","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/59744","datePublished":"2026-11-17T18:35:20.000Z","dateModified":"2026-11-17T18:35:20.000Z","language":"en","abstract":"GSK completed its $10.6 billion acquisition of Nuvalent in July, adding three lung cancer assets to its portfolio.","section":"Regulation","references":[{"title":"TokenPost’s earlier coverage of the deal","url":"https://www.tokenpost.com/news/business/41894"}]}